Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis
The competition with G-CSF biosimilars varies significantly between EU-5 countries, probably because of G-CSF distribution channel differences. Currently, this competition is not mainly based on prices, but on local political options to stimulate tendering between them and recently branded second- or third-generation products. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Year of publication: |
2014
|
---|---|
Authors: | Bocquet, François ; Paubel, Pascal ; Fusier, Isabelle ; Cordonnier, Anne-Laure ; Pen, Claude ; Sinègre, Martine |
Published in: |
Applied Health Economics and Health Policy. - Springer, ISSN 1175-5652. - Vol. 12.2014, 3, p. 315-326
|
Publisher: |
Springer |
Saved in:
Saved in favorites
Similar items by person
-
Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis
Bocquet, François, (2014)
-
Bocquet, François, (2015)
-
Bocquet, François, (2015)
- More ...